Is PRTG undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Portage Biotech Inc (PRTG) is -317.00 USD. This PRTG valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.20 USD, the upside of Portage Biotech Inc is -7,647.70%. This means that PRTG is overvalued by 7,647.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -317.00 - -317.00 | -317.00 | -7,647.70% |
| DDM - Stable | (548.04) - (1,870.16) | (1,209.10) | -28888.0% |
| DDM - Multi | (518.32) - (1,408.93) | (761.86) | -18239.6% |
| Market Cap (mil) | 4.71 |
| Beta | 0.99 |
| Outstanding shares (mil) | 1.12 |
| Enterprise Value (mil) | 1.41 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.57% |
| Cost of Debt | 5.00% |
| WACC | 9.52% |